RLFTF

MindMaze Therapeutics Holding SA

$0.21
+0.03 +17.98% today

Price History

Not enough data

Key Stats

Market Cap
2.65M
Avg Volume
4,218
EPS
-$1.70
52W High
$4.88
52W Low
$0.16
Div. Yield
0.0%

Valuation

P/B Ratio
0.71
P/S Ratio
4.39

Margins

Gross Margin 92.1%
Operating Margin (1637.8%)
Net Margin 0.0%
EBITDA Margin 0.0%

Growth & Returns

Return on Equity
(51.6%)
Return on Assets
(25.5%)

Liquidity & Leverage

Current Ratio
1.20
Quick Ratio
1.05

About

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

mindmazetherapeutics.com